NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Down 17.0 % NYSEAMERICAN NBY opened at $0.73 on Friday. The company’s fifty day simple moving average is $0.92 […]

Related Keywords

United States , ,Institutional Trading Of Novabay Pharmaceuticals ,Novabay Pharmaceuticals ,Virtu Financial ,Renaissance Technologies ,Armistice Capital ,News Ratings For Novabay Pharmaceuticals Daily ,Novabay Pharmaceuticals Company Profile ,Novabay Pharmaceuticals Inc ,Novabay Pharmaceuticals Trading Down ,Get Rating ,Bay Pharmaceuticals Trading Down ,Bay Pharmaceuticals ,Avenova Spray ,Novabay Pharmaceuticals Daily ,Nyseamerican Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,